Frontiers in Endocrinology (Jul 2023)

Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review

  • Denise H. van Abswoude,
  • Denise H. van Abswoude,
  • Denise H. van Abswoude,
  • Denise H. van Abswoude,
  • Karlijn Pellikaan,
  • Karlijn Pellikaan,
  • Karlijn Pellikaan,
  • Karlijn Pellikaan,
  • Naomi Nguyen,
  • Anna G. W. Rosenberg,
  • Anna G. W. Rosenberg,
  • Anna G. W. Rosenberg,
  • Anna G. W. Rosenberg,
  • Kirsten Davidse,
  • Kirsten Davidse,
  • Kirsten Davidse,
  • Kirsten Davidse,
  • Franciska M. E. Hoekstra,
  • Franciska M. E. Hoekstra,
  • Ilse M. Rood,
  • Christine Poitou,
  • Christine Poitou,
  • Christine Poitou,
  • Graziano Grugni,
  • Graziano Grugni,
  • Graziano Grugni,
  • Charlotte Høybye,
  • Charlotte Høybye,
  • Charlotte Høybye,
  • Charlotte Høybye,
  • Tania P. Markovic,
  • Tania P. Markovic,
  • Tania P. Markovic,
  • Assumpta Caixàs,
  • Assumpta Caixàs,
  • Assumpta Caixàs,
  • Antonino Crinò,
  • Antonino Crinò,
  • Antonino Crinò,
  • Sjoerd A. A. van den Berg,
  • Sjoerd A. A. van den Berg,
  • Aart J. van der Lely,
  • Aart J. van der Lely,
  • Aart J. van der Lely,
  • Laura C. G. de Graaff,
  • Laura C. G. de Graaff,
  • Laura C. G. de Graaff,
  • Laura C. G. de Graaff,
  • Laura C. G. de Graaff

DOI
https://doi.org/10.3389/fendo.2023.1168648
Journal volume & issue
Vol. 14

Abstract

Read online

BackgroundPrader-Willi syndrome (PWS) is a rare, complex, genetic disorder characterized by hyperphagia, hypotonia, delayed psychomotor development, low muscle mass and hypothalamic dysfunction. Adults with PWS often have obesity, hypertension and type 2 diabetes mellitus (DM2), known risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD). Early symptoms of CVD and CKD may be masked by intellectual disability and inability to express physical complaints. Furthermore, kidney diseases are often asymptomatic. Therefore, renal and cardiovascular disease might be missed in patients with PWS. Microalbuminuria is an early sign of microvascular damage in the kidneys and other vascular beds. Therefore, we screened our adult PWS cohort for the presence of elevated urinary albumin and (micro)albuminuria.MethodsWe retrospectively collected anthropometric measurements, blood pressure, medical history, medication use, urine dipstick and biochemical measurements form electronic patient files. In addition, we performed a systematic literature review on kidney disease in PWS.ResultsWe included 162 adults with genetically confirmed PWS (56% male, median age 28 years), of whom 44 (27%) had DM2. None had known CVD. All subjects had normal estimated glomerular filtration rate (eGFR) according to non-PWS reference intervals. Elevated urinary albumin or (micro)albuminuria was present in 28 (18%); 19 out of 75 (25%) had an increased urinary albumin-to-creatinine ratio (UACR) and 10 out of 57 (18%) had an increased urinary protein-to-creatinine ratio. Elevated urinary albumin was present at a young age (median age 26 (IQR 24-32) years) and was associated with an significantly higher BMI and LDL-cholesterol levels and higher prevalence of DM2, hypertension and dyslipidemia than those with normal UACR (p=0.027, p=0.019, p<0.001, p<0.001, p=0.011 and respectively).ConclusionUpon screening, one in every five adults with PWS had increased urinary albumin or (micro)albuminuria, early signs of microvascular disease. All had normal eGFR, according to non-PWS reference intervals, and none had a formal diagnosis of CVD. As muscle mass is low in PWS, creatinine levels and eGFR may be spuriously normal. Urinalysis in this patient group can be used as a screening tool for microvascular (kidney) disease. We propose an algorithm for the detection and management of microvascular disease in adults with PWS.

Keywords